clomipramine has been researched along with evans blue in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fukushima, K; Ito, Y; Kobuchi, S; Shibata, M; Sugioka, N; Takada, K | 1 |
2 other study(ies) available for clomipramine and evans blue
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Pharmacokinetics of clomipramine, an antidepressant, in poloxamer 407-induced hyperlipidaemic model rats.
Topics: Animals; Antidepressive Agents; Blood-Brain Barrier; Brain; Clomipramine; Disease Models, Animal; Evans Blue; Hyperlipidemias; Lipoproteins; Male; Plasma; Poloxamer; Protein Binding; Rats; Rats, Wistar | 2011 |